Sat, Dec 20, 2014, 2:55 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Aethlon Medical, Inc. Message Board

  • andy55q andy55q Jun 17, 2013 9:34 AM Flag

    CytoSorbents Announces FDA Approved

    8:00AM CytoSorbents Announces FDA Approved US Air Force Funded Human Trauma Pilot Study for Rhabdomyolysis (CTSO) 0.12 : Co announced that the United States Food and Drug Administration (FDA) has granted approval to begin a U.S.-based human pilot study using CytoSorb? for the treatment of rhabdomyolysis as a result of trauma under an Investigational Device Exemption (IDE). Rhabdomyolysis is caused by the massive release of myoglobin from severely injured skeletal muscle that can lead to kidney failure. The study was initiated by and will be funded by the U.S. Air Force. CytoSorbents is the official sponsor of the study, and expects the study to begin this year.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.264-0.016(-5.88%)Dec 19 3:59 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
3M Company
NYSEFri, Dec 19, 2014 4:04 PM EST
ImmunoGen, Inc.
NASDAQFri, Dec 19, 2014 4:00 PM EST
Southwestern Energy Co.
NYSEFri, Dec 19, 2014 4:05 PM EST